All Episodes
The Syneos Health Podcast — 196 episodes
Introducing: Early Signals
Site Realities Series | Navigating Complexity: Communication, Escalation Paths and Site Partnership at Scale
Site Realities Series | Building Trust at the Site Level: The CRA as Ambassador and Partner
Introducing: Conversations on Commercialization
Site Realities Series | From Monitor to Strategic Partner: The Evolution of the CRA Role
Site Realities Series | Inside the Site Experience: Challenges, Tradeoffs and Opportunities
Conversations on Commercialization: Navigating Dermatology’s New Access Landscape with Paul Rittman of Almirall US
Functionally Speaking Series: Regulatory Intelligence, Medical Writing and the AI Inflection Point
Functionally Speaking Series: Reimagining Site Experience: CRAs, AI and the Future of Functional Models
Functionally Speaking Series: Modernizing Safety and Pharmacovigilance, The Human in the Loop
Functionally Speaking Series: Clinical Operations for Large Pharma, Navigating Model Evolution With Agility
Functionally Speaking Series: FSP for SMID Sponsors, Navigating Complexity with Flexibility and Trust
2025 CNS Summit Series: Scaling Psychedelic Medicines Responsibly, A Conversation with Dr. Dan Karlin, CSO, MindMed
2025 CNS Summit Series: Revolutionizing Clinical Trials with Virtual Patients, A Conversation with Anzar Abbas, CEO, Brooklyn Health
2025 CNS Summit Series: Rewriting the Rules of Neurodegeneration, A Conversation with Arvinas CSO Angela Cacace, PhD
CNS Summit Series: Balanced Disruption in Neurology, A Conversation with Merz Therapeutics CEO Stefan König
Conversations on Commercialization: Changing the Name Game with Addison Whitney’s Ari™
CNS Summit Series: Can Psychedelics Reshape Psychiatry? A Conversation with Kabir Nath, CEO, Compass Pathways
Conversations on Commercialization: GLP-1 Gold Rush — Who’s Really Winning in the New Obesity Market?
Conversations on Commercialization: DTP, AI and the Future of Pharma Access
Conversations on Commercialization: The New Rules of HCP Engagement
2025 Health Trends | Getting Real About Omnichannel: A View from the Leading Edge
Asembia AXS25 Series: Redefining Access for Enhanced Retail Therapies, with Cheryl Allen of Curatio Advisors
Asembia AXS25 Series: Reimagining Patient Support: Scaling Access, Affordability and AI Integration with Kelly Carter of Amgen
Asembia AXS25 Series: Redefining Market Access: Patient Support, Technology and Pharma Strategy with Rob Truckenmiller of PharmaCord
Asembia AXS25 Series: Holistic Patient Support with Tiara Green of Accessia Health
Asembia AXS25 Series: Modernizing Patient Services: AI, Hybrid Models and Innovation Strategy with Greg Morris of CareMetx
Project Optimus Series: Clinical Pharmacology and Project Optimus
2025 Health Trends | Strategy, Agility and Innovation in Launch Excellence
2025 Health Trends | AI as an R&D Investment
Asembia AXS25 Series: Navigating Modern Market Access
Project Optimus Series: The Role of Biostatistics
Project Optimus Series: Operationalizing Dose Optimization
Opportunities Abound for PDTs, with Click Therapeutics
Unlocking the Black Box of Psychiatric Clinical Research, with Dr. Rishi Kakar of Segal Trials
Project Optimus Series: The Regulatory Implications of Project Optimus
CNS Summit Series: Pioneering Patient Advocacy, with Ryan Brooks from CenExel
CNS Summit Series: Future-Proofing Clinical Trials
CNS Summit Series: Pioneering Psychiatry - Behind the Breakthrough KarXT with Dr. Stephen Brannan
CNS Summit Series: Decoding Biology to Radically Change the Lives of Patients, with Dr. Najat Khan of Recursion Pharma
CNS Summit Series: Schizophrenia, Clinical Trials and Hope, with Dr. David Walling of Cenexel CNS
CNS Summit Series: The Future of Immunology and Personalized Health,with Jane Metcalfe of The Human Immunome Project
CNS Summit Series: Psychedelics and Beyond, with Kevin Craig of atai Life Sciences
CNS Summit Series: Redefining Psychiatry with Science and Compassion, with Dr. David Brown of Community Clinical Research
CNS Summit Series: Patient-Centric Innovation at Scale, with Cristina Duran of Evinova
CNS Summit Series: Celebrating 15 Years of Innovation with Dr. Amir Kalali of CNS Summit
Project Optimus Series: Navigating the Realities of Project Optimus
Psychedelics 3.0: Challenges and Opportunities in an Evolving Field
A Site-Specific Approach to Optimizing Diversity in Oncology Trials
Circulating Tumor DNA: Transforming Oncology Clinical Trials
Cashing in on the Currency of Information
Decoding Gen AI’s Potential to Drive More Effective Clinical Trials
Connecting the Global Dots on Carbon Footprint in Biopharma
Can AI Help Get the Right Patients Into Alzheimer's Clinical Trials?
Unpacking the Role of Adjuvant Therapies in Breast Cancer
Site and Study Execution for Ophthalmology Trials
The Case for Genetic Medicines
Jeff Stewart Says Goodbye
Patient Assistance: The Best Deal in Pharma
Real Talk About the Inflation Reduction Act
Turbo-Charging Clinical Trials
Investing for Commercial Success as an Emerging Company
Ophthalmology Clinical Trials: Low Vision and AMD Awareness Month
FDA Rules for Radio & TV Advertising
2024 Health Trends: Managing the Healthcare Revolution
World Mental Health Day: The State of Mental Health Clinical Development
Radiosensitizers in Head and Neck Cancer
Market Access for Weight Loss Drugs
Training MSLs in the Metaverse
Biopharma and the Emergency Department
Biotech Value Creation
2023 Health Trends: Improved Sophistication in Retention
Digital Therapeutic Development and Approval
Digital Therapeutic Commercialization
Cancer: The Patient Perspective
2023 Health Trends: The Data Effect
2023 Health Trends: A New Field for the Field Force
2023 Health Trends: Digital Transformation: Start, Stall, Restart
Gene Therapy for Hemophilia
The Inflation Reduction Act
2023 Health Trends: AI: Finally Fit for Purpose
2023 Health Trends: AgeTech with Musician, Actor and Patient Advocate James Ian
Reg Ops Edition: Attracting and Retaining Talent
Life Sciences Dealmaking: Dealmakers' Intentions 2023
2023 Health Trends: Personally, Purposefully Building What’s Next
Real World Evidence and Rare Diseases, Part 3: The Value of Registries
Decentralized Clinical Trials: Implications for Biotech
Full-Service Commercial
MAPS Edition: Value Demonstration - A View From the Top
MAPS Edition: Bringing Medical Affairs Into the C-Suite
Opportunities and Challenges in Cell and Gene Therapy
MAPS Edition: Recruiting for the New Profile of Medical Affairs
MAPS Edition: Stakeholder Engagement in a Data-Driven Environment
MAPS Edition: Measuring the Immeasurable: Value and Impact of Medical Affairs
MAPS Edition: Be Bold - Preparing Medical Affairs for 2030 and Beyond
Training the Next Generation of Pharma
Getting Access
Epilepsy, the Central Nervous System and Rare Disease
The Placebo Effect
Mental Health in Rare Disease
Navigating the Rare Disease Landscape
Business Continuity Through Strategic Outsourcing
The Virtual Sales Organization
Thirty Years of Physician Answers
Syneos Short: Talking to Our Families About COVID-19 Vaccines
2021 HEALTH TRENDS EDITION: Leading Change in China
2021 HEALTH TRENDS EDITION: Field Force of the Future
2021 HEALTH TRENDS EDITION: Omnichannel Experience
Storytelling in Pharma
2021 HEALTH TRENDS EDITION: Remote Care in 2021 and Beyond
Virtual Pharma
Pharmacovigilance in the COVID-19 Era and Beyond
Lifecycle Management
Source Document Review in the Modern World
Learning Agility in Medical Affairs
Trade and Distribution in Pharma: It's Complicated
Peter Kolchinsky and Investing in Biopharma
Peter Kolchinsky and The Great American Drug Deal
Real World Evidence and Rare Diseases
Global Pharma
APAC EDITION: Clinical Development in Japan
Learning Agility
China vs. Cancer
Rapid Early Phase Clinical Trials
Payer Power, Part 3
CORONAVIRUS SPECIAL EDITION, Episode 12: COVID-19 and Children
CORONAVIRUS SPECIAL EDITION, Episode 11: Rare Disease Clinical Trials and COVID-19
NEWYORKBIO BIOPHARMA INNOVATORS SERIES: Yelp Ratings for Clinical Trials
NEWYORKBIO BIOPHARMA INNOVATORS SERIES: Taming the Healthcare Data Explosion
NEWYORKBIO BIOPHARMA INNOVATORS SERIES: Real World Data for Clinical Innovation
CORONAVIRUS SPECIAL EDITION, Episode 10: Ventilating the COVID-19 Patient
CORONAVIRUS SPECIAL EDITION, Episode 9: Telemedicine in the Age of COVID-19
CORONAVIRUS SPECIAL EDITION, Episode 8: Payers and COVID-19
CORONAVIRUS SPECIAL EDITION, Episode 7: Continuity in Clinical Trials
CORONAVIRUS SPECIAL EDITION, Episode 6: The Leader's Experience
CORONAVIRUS SPECIAL EDITION, Episode 5: Surviving the Ventilator Shortage
CORONAVIRUS SPECIAL EDITION, Episode 4: Clinical Trials Through Pandemics
CORONAVIRUS SPECIAL EDITION, Episode 3: Virtual Clinical Trials
CORONAVIRUS SPECIAL EDITION, Episode 2: The Clinical Experience
CORONAVIRUS SPECIAL EDITION, Episode 1: The Personal Experience
Recruiting Patients for Clinical Trials
Medical Affairs Series, Part Six: Commercial Plus Medical Affairs
2020 Health Trends: Box Store Healthcare
Denials, Delays and Deep Discounts in Pharmaceutical Launch
Medical Affairs Series, Part Five: Medical Affairs in the Early Stage
Real World Evidence and Rare Diseases
The Digital Therapeutics Alliance: A European Perspective
Medical Affairs Series, Part Four: Medical Affairs in the Field
Medical Affairs Series, Part Three: Moving to the Left
Advocacy Archetypes
Medical Affairs Series, Part Two - Measuring the Unmeasurable: Medical Affairs Metrics
Why We Resist
Medical Affairs Series, Part One: A Foundation for Medical Affairs
A Regulatory Roadmap for Real World Evidence
Talented Teams
Digital Therapeutics
Talking About PIE
MOAs in ONC: The Latest and Greatest in the Oncology Pipeline
Episode 037: Psychology in Clinical Trials
Episode 036: Commercialization for Emerging Companies
Episode 035: How Translational Science Can Solve Pharma's Productivity Puzzle
Episode 034: Can the Gut Microbiome Revolutionize Medical Care?
APAC Edition: Medical Affairs in China
Episode 033: From DTC to DT"Me" - The Future of Communications in Pharmaceuticals
Episode 032: Navigating the New EU Medical Device Regulations
APAC Edition: Acceleration in Asia
Episode 031: Real World Evidence in Europe
Episode 030: Land of Opportunity: R&D in Asia Pacific
Episode 029: Commercial Models of the (Very Near) Future
Episode 028: World Cancer Day
Episode 027: Caregivers
Episode 026: The Health Trend Ten - Clinical Perspective
Episode 025: The Health Trend Ten - Commercial Perspective
Episode 024: Content that Clicks
Episode 023: The Clinical Trial Marathon, at a Sprint
Episode 022: Spending for Launch Success
Episode 021: The Sales Force Training (R)evolution
Episode 020: A Syneos Health Short - 21st Century Cures
Episode 019: A Decade of Dealmakers' Intentions
Episode 018: Partnering with a CRO
Episode 016: Payer Power, Part 2
Episode 015: ICER - Friend or Foe?
Episode 014: MA-"Squared": Medical Affairs Meets Market Access
Episode 009: Rare Diseases
Episode 013: Artificial Intelligence for Authentic Engagement
Episode 012: Medical Affairs from Zero
Episode 011: Naming, Part 2 - The Drug
Episode 010: Naming, Part 1 - The Pharma Company
Episode 008: Social Centricity
Episode 007: Medicine in 140 Characters: Digital KOLs
Episode 006: Crossing the Finish Line: Factors Driving Patient Adherence to Drug Therapy
Episode 005: The Room Where it Happens: Dealmakers' Intentions 2017
Episode 004: Innovation in Pharma Communications
Episode 003: Payer Power
Episode 002: The Impact of AHCA on Pharma
Episode 001: The Real-World Evidence Revolution